Back to Results
First PageMeta Content
Medicine / Intersect ENT / Propel mometasone furoate implant / Otorhinolaryngology / Sinusitis / Sinus


Intersect ENT Recognized for Gender Diversity by Watermark and UC Davis Company Also Recognized in Deloitte’s 2015 Technology Fast 500 MENLO PARK, Calif., November 17, 2015 – Intersect ENT, Inc. (Nasdaq:XENT), a comp
Add to Reading List

Document Date: 2015-11-17 11:28:47


Open Document

File Size: 27,38 KB

Share Result on Facebook
UPDATE